cancer weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of cancer weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Epstein-Barr Virus
Researchers publish new studies and findings in the area of epstein-barr virus
October 25th, 2005
New findings from Germany and Sweden describe advances in epstein-barr virus. Study 1: Scientists examined the impact latent Epstein-Barr virus (EBV) infection has on the outcome of pediatric Hodgkin lymphoma (HL). "The prognostic significance of EBV infection in HL is debated controversially. Especially in the pediatric age group, no conclusive data are available. Eight hundred forty-two children and adolescents (median age, 13.7 years) from pediatric multicenter treatment studies HD-90 and HD-95 were studied for latent EBV infection in Hodgkin and Reed-Sternberg cells by immunostaining against latent membrane protein 1 (LMP-1)," researchers in...
Source: cancer weekly (2005-10-25)
|
